Tirzepatide 10mg / 30mg Peptide Canada

Dual GIP / GLP‑1 Receptor Agonist for Advanced Metabolic Research in Canada

Tirzepatide peptide is a high‑purity, synthetic dual‑agonist research compound studied in laboratory settings for its interaction with GIP (glucose‑dependent insulinotropic polypeptide) and GLP‑1 (glucagon‑like peptide‑1) receptor pathways. Its unique ability to engage two incretin receptor systems simultaneously makes it a valuable tool in advanced metabolic and signaling research.

Supplied by BlueNexLabs, Tirzepatide is provided as a lyophilized research peptide (10 mg or 20mg) with COA‑verified purity, optimized for Canadian research laboratories requiring audit‑safe RUO reagents.

Tirzepatide is designed as a synthetic peptide analog that enables controlled investigation of multi‑receptor incretin signaling in in‑vitro and preclinical research models. By activating both GIPR and GLP‑1R, it supports experimental exploration of how coordinated receptor engagement influences:

• Metabolic signal integration
• Energy‑regulation pathways
• Receptor bias and signaling efficiency
• Peptide structure–function relationships

Because of its dual‑agonist architecture, Tirzepatide is frequently used as a model compound in studies examining multi‑pathway peptide mechanisms and receptor crosstalk.

Tirzepatide is intended strictly for laboratory research use and is commonly applied in:

• Dual‑receptor binding studies

• cAMP & intracellular signaling assays

• Peptide–receptor kinetics research

• Structure–function & stability studies

• Analytical & method development

All applications remain non‑clinical and research‑only.

Type: Synthetic dual‑agonist peptide (GIPR + GLP‑1R)

Form: Lyophilized peptide powder

Size: 10 mg vial

Identity Verification: Mass Spectrometry (MS)

Purity Analysis: HPLC / UPLC

Structural Features

• Sequence‑level substitutions designed to improve enzymatic stability
• Fatty‑acid side chain enabling albumin interaction in vitro
• Demonstrates dual‑receptor engagement with measurable receptor bias

Biochemical Behavior

• Solubility dependent on pH, buffer system, and ionic strength
• Lipidated peptides may aggregate if improperly prepared
• Sensitive to oxidation and hydrolysis post‑reconstitution

• Store lyophilized peptide at –20 °C, protected from light and moisture
• Reconstituted solutions: 2–8 °C, short‑term research use only
• Avoid repeated freeze–thaw cycles
• Aliquot after reconstitution if required
• Use low‑binding laboratory consumables to reduce peptide adsorption

Each batch of Tirzepatide supplied by BlueNexLabs includes audit‑ready documentation, consisting of:

• MS identity confirmation
• HPLC / UPLC purity results
• Solvent system disclosure
• Lot & batch traceability

🔗 View Certificate of Analysis (COA)

🔗Learn About Our Testing Standards

Learn about documentation standards in the FAQ

Tirzepatide lots are research-use only. Confirm the vial size on the Certificate of Analysis; a 10 mg report does not document a 30 mg fill.

Research-use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.